These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18851906)

  • 61. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.
    Jónsdóttir H; Friis S; Horne R; Pettersen KI; Reikvam A; Andreassen OA
    Acta Psychiatr Scand; 2009 Jan; 119(1):78-84. PubMed ID: 18983630
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.
    Roe D; Goldblatt H; Baloush-Klienman V; Swarbrick M; Davidson L
    Psychiatr Rehabil J; 2009; 33(1):38-46. PubMed ID: 19592378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between attitude toward medication and neurocognitive function in schizophrenia.
    Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
    Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
    Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
    Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Understanding adherence to neuroleptic treatment in schizophreniaí.
    Vauth R; Löschmann C; Rüsch N; Corrigan PW
    Psychiatry Res; 2004 Apr; 126(1):43-9. PubMed ID: 15081626
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methodological challenges in psychiatric treatment adherence research.
    Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.
    Moritz S; Hünsche A; Lincoln TM
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DAI-10 is as good as DAI-30 in schizophrenia.
    Nielsen RE; Lindström E; Nielsen J; Levander S
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):747-50. PubMed ID: 22440974
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stigma, discrimination and medication adherence in schizophrenia: results from the Swedish COAST study.
    Brain C; Sameby B; Allerby K; Quinlan P; Joas E; Lindström E; Burns T; Waern M
    Psychiatry Res; 2014 Dec; 220(3):811-7. PubMed ID: 25457284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
    Mohamed S; Rosenheck R; McEvoy J; Swartz M; Stroup S; Lieberman JA
    Schizophr Bull; 2009 Mar; 35(2):336-46. PubMed ID: 18586692
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
    Wilder CM; Elbogen EB; Moser LL; Swanson JW; Swartz MS
    Psychiatr Serv; 2010 Apr; 61(4):380-5. PubMed ID: 20360277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long- and short-term inpatients with schizophrenia in China: implications for community-based service development.
    Wu G; Ouyang X; Yang B; Li L; Wang Z; Yi W; Liu C; Wang P; Chiu HF; Lee E; Xue Z; Rosenheck R; Liu Z
    Asia Pac Psychiatry; 2013 Mar; 5(1):E39-46. PubMed ID: 23857794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. "When I Stop My Medication, Everything Goes Wrong": Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication.
    Niemeyer L; Schumm L; Mechler K; Jennen-Steinmetz C; Dittmann RW; Häge A
    J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):655-662. PubMed ID: 30148662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Strategies for measuring medication adherence in patients with schizophrenia].
    Wang Y; Huang Z; Xu D; Gong W; Tang Y; Xiao S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):218-24. PubMed ID: 26932222
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
    Misdrahi D; Tessier A; Swendsen J; Berna F; Brunel L; Capdevielle D; Chereau I; Danion JM; De Pradier M; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Llorca PM; Fond G;
    J Clin Psychiatry; 2016 Sep; 77(9):e1130-e1136. PubMed ID: 27780318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.
    Teferra S; Hanlon C; Beyero T; Jacobsson L; Shibre T
    BMC Psychiatry; 2013 Jun; 13():168. PubMed ID: 23773362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Awareness of illness in schizophrenia and outpatient treatment adherence.
    Cuffel BJ; Alford J; Fischer EP; Owen RR
    J Nerv Ment Dis; 1996 Nov; 184(11):653-9. PubMed ID: 8955677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.